Cladribine is a medication used to treat hairy cell leukemia (HCL, leukemic
reticuloendotheliosis) and B-cell chronic lymphocytic leukemia. Its chemical
name is ...
(KLA-drih-bean). Trade name: Leustatin<sup>TM</sup> Other names: 2-CdA, 2-
Chlorodeoxyadenosine. Cladribine is the generic name for the trade name drug
Jun 15, 2016 ... Cladribine injection must be given in a hospital or medical facility under the
supervision of a doctor who is experienced in giving chemotherapy ...
Sep 11, 2015 ... Cladribine is a type of chemotherapy that belongs to a class of drugs called
antimetabolites. These medications are taken up by cells and are ...
Cladribine differs structurally from deoxyadenosine only by the presence of a
chlorine atom at position 2 of the purine ring, which results in resistance to ...
Find a comprehensive guide to possible side effects including common and rare
side effects when taking Leustatin (Cladribine Injection For Intravenous Infusion ...
WARNING. LEUSTATIN (cladribine) Injection should be administered under the
supervision of a qualified physician experienced in the use of antineoplastic ...
My father 60 years, was given 5-day Cladribine from March 30-April 3. His blood
counts almost after 2 months are around TLC- 2000, Hg- 8.9, Platelets- 52000, ...
Addition of Cladribine to Idarubicin and Cytarabine during Induction Increases
the Overall Efficacy Rate in Adult Patients with Acute Myeloid Leukemia: A ...
Cladribine mechanism of action. 2-CdA enters the cell through an efficient
transport system. Cladribine is resistant to deamination by ADA. The high DCK to